Literatur
-
1
Lechat P, Mas J L, Lascault G.
Prevalence of patent foramen ovale in patients with stroke.
NEJM.
1988;
318
1148-1152
-
2
Homma S, Sacco R L, Di Tullio M R, Sciacca R R, Mohr J P. for the Cryptogenic Stroke Study (PICSS) investigators .
Effect of medical treatment in stroke patients with patent foramen ovale. Patent foramen ovale in cryptogenic stroke study.
Circulation.
2002;
105
2625-2631
-
3
Steiner M M, Di Tullio M R, Rundek T. et al .
Patent Foramen Ovale Size and Embolic Brain Imaging Findings Among Patients With Ischemic Stroke.
Stroke.
1998;
29
944-948
-
4
Bogousslavsky J, Garazi S, Jeanrenaud X. et al .
Stroke recurrence in patients with patent foramen ovale: The Lausanne study.
Neurology.
1996;
46
1301-1305
-
5
Mas J L, Zuber M.
Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysma, or both and cryptogenic stroke or transient ischemic attack.
Am Heart J.
1995;
130
1083-1088
-
6
Mas J L, Arquizan C, Lamy C. et al .
Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both.
NEJM.
2001;
345
1740-1746
-
7
Bauriedel G, Skowasch D, Jabs A. et al .
Therapieoptionen bei symptomatischem offenen Foramen ovale: Eine aktuelle Bestandsaufnahme katheterinterventioneller Verfahren.
Dtsch Arztebl.
2003;
100
A2230-2235
-
8
Khairy P, O’Donnell C P, Landzberg M J.
Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli.
Ann Intern Med.
2003;
139
753-760
-
9
Windecke S, Wahl A, Nedeltchev K. et al .
Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.
J Am Coll Cardiol.
2004;
44
750-758
-
10
Schuchlenz H W, Weihs W, Berghold A. et al .
Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale.
Int J Cardiol.
2005;
101
77-82
-
11
Wahl A, Krumsdorf U, Meier B. et al .
Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients.
J Am Coll Cardiol.
2005;
45
377-380
Prof. Dr. Roman Haberl
Abteilung für Neurologie, Klinikum Harlaching, Städtisches Klinikum München GmbH
Sanatoriumsplatz 2
81545 München
